Generic drugs in the US are too cheap to be sustainable, experts say

Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business

Generic drugs are the singularity of American healthcare – they are too cheap. And it’s driving some manufacturers out of business altogether.

Drug prices regularly sparks recrimination and outrage on Capitol Hill, such as a recently announced investigation by Senate Democrats and Bernie Sanders into the price of albuterol inhalers.